1BECK H,TITZE S I,HUBNER S,et al. Heart failure in a cohort of patients with chronic kidney disease : the GCKD study [ J]. PLoS One,2015,10(4) : e0122552.
2SONG W H,WANG X M. The role of TGF-β1 and LRG1 in cardiac remodelling and heart failure [ J ]. Biophys Rev, 2015 (7) :91-104.
5BURKLY L C. Regulation of tissue responses:the TWEAK/ Fn14 pathway and other TNF/TNFR superfamily members thatactivate non- canonical NF- κB signaling [ J]. Front Immunol, 2015,6:92.
6NOVOYATLEVA T,DIEHL F,van AMERONGEN M J, et al. TWEAK is a positive regulator of cardiomyoeyte proliferation [ J ]. Cardiovascular Research,2010,85 (4) : 681- 690.
7NOVOYATLEVA T, SCHYMURA Y,JANSSEN W, et al. Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction[ J ]. Basic Research in Cardiology, 2013, 108 (2) : 1-13.
8SANZ A B, SANCHEZ-NINO M D, IZQUIERDO M C, et al. Tweak induces proliferation in renal tubular epithelium:a role in uninephrectomy induced renal hyperplasia [ J ]. Journal of Cellular and Molecular Medicine,2009,13 (9b) :3329-3342.
9PIATKOWSKI T, MUHLFELD C, BORCHARDT T, et al. Reconstitution of the myocardium in regenerating newt hearts is preceded by transient deposition of extracellular matrix components [ J ]. Stem Ceils and Development, 2013, 22 ( 13 ) : 1921-1931.
10NOVOYATLEVA T, JANSSEN W, WIETELMANN A, et al. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy [ J ]. Cytokine, 2013,64 ( 1 ) :43-45.
二级参考文献37
1VAN KIMMENADE R R,JANUZZI J J.Emerging biomarkers in heart failure[J].Clin Chem,2012,58(1):127-138.
2REN M Y,SUI S J.The role of TWEAK/Fn14 in cardiac remodeling[J].Mol Biol Rep,2012,39(11):9971-9977.
3CHORIANOPOULOS E,ROSENBERG M,ZUGCK C,et al.Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure[J].Eur J Heart Fail,2009,11(11):1050-1056.
4HASEGAWA K,IWAI KANAI E,SASAYAMA S.Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure[J].J Cell Physiol,2001,186(1):11-18.
5LEE D S,AUSTIN P C,ROULEAU J L,et al.Predicting mortality among patients hospitalized for heart failure:derivation and validation of a clinical model[J].JAMA,2003,290(19):2581-2587.
6CHICHEPORTICHE Y,BOURDON P R,XU H,et al.TWEAK,a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis[J].J Biol Chem,1997,272(51):32401-32410.
7RICHTER B,RYCHLI K,HOHENSINNER P J,et al.Diffe rences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure[J].Atherosclerosis,2010,213(2):545-548.
8JAIN M,JAKUBOWSKI A,CUI L,et al.A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure[J].Circulation,2009,119(15):2058-2068.
9BOVER L C,CARDO VILA M,KUNIYASU A,et al.A previously unrecognized protein-protein interaction between TWEAK and CD163:potential biological implications[J].J Immunol,2007,178(12):8183-8194.
10MUNOZ GARCIA B,MADRIGAL-MATUTE J,MORENO J A,et al.TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells[J].Cardiovasc Res,2011,89(1):225-233.
